FDA Looks to Ease Stakeholder Confusion Over UDI Direct Marking Requirements

The GMP Letter
A A
The FDA is clarifying language related to the direct marking of medical devices for unique device identification purposes, including the definition of reprocessing.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00